private:netscientific
|
990335
|
May 30th, 2019 12:00AM
|
NetScientific Group plc
|
424
|
7.00
|
Open
|
Venture Capital & Private Equity
|
May 30th, 2019 01:37PM
|
May 30th, 2019 01:37PM
|
NetScientific is a transatlantic healthcare IP commercialisation group focused on sourcing, funding and commercialising technologies that significantly improve the health and well-being of people with chronic diseases.
NetScientific invests in early stage healthcare technology companies sourced from strategic partnerships and relationships in the US and Europe, building businesses to address unmet medical needs related to chronic disease through digital health, diagnostics and therapeutics.
NetScientific identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor, providing portfolio Companies with extensive management support and technical guidance as well as access to legal, IP and commercial expertise. As companies mature through key milestones the Group recruits experienced industry leading CEOs to drive the next phase of growth and attracts additional external capital to secure favourable exits.
Our core portfolio companies* are:
- Vortex Biosciences
- Glycotest
- WANDA Health
- ProAxsis
- PDS Biotechnology
*NetScientific has a majority stake in all its core portfolio companies with the exception of PDS Biotechnology
|
Open
|
|
Open
|
6 Bevis Marks, Bury Ct, 12th Floor
|
London
|
London
|
GB
|
EC3A 7BA
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 17th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 16th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 15th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 14th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 13th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 12th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 11th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 10th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|
private:netscientific
|
990335
|
Feb 9th, 2018 12:00AM
|
NetScientific Group plc
|
355
|
9.00
|
Open
|
Venture Capital & Private Equity
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
NetScientific's mission is to build a transatlantic biomedical and healthcare group funding and developing technologies that offer transformative benefits to people's lives and society.
NetScientific funds, develops and manages early/mid-stage healthcare technology companies sourced from strategic partnerships and relationships in USA and Europe with a primary focus on Digital health, Diagnostics and Therapeutics. These represent highly attractive growth markets where breakthrough technology solutions are in high demand.
NetScientific’s investment model identifies late-stage translational research projects developing cutting-edge technologies in its disease focus areas. NetScientific then builds on accredited research, the previous stages of which have already been funded by academic institutions, governments and science foundations, to take the projects to the point of commercialisation.
NetScientific is an active investor providing extensive management support. This can involve the senior management team initially taking leadership roles in companies and building dedicated management teams as the companies develop and grow.
|
|
|
|
|
|
|
|
|
|
NetScientific
|
Health Care
|
Pharmaceuticals & Biotechnology
|